We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

166 hedge funds and large institutions have $2.74B invested in AVANIR PHARMACEUTICALS, INC CL A in 2014 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 45 increasing their positions, 42 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $54.8M | Put options by funds: $23.9M

57% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 44

42% more capital invested

Capital invested by funds: $1.93B → $2.74B (+$812M)

17% more funds holding

Funds holding: 142166 (+24)

7% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 42

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

Holders
166
Holders Change
+24
Holders Change %
+16.9%
% of All Funds
4.43%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.08%
New
69
Increased
45
Reduced
42
Closed
44
Calls
$54.8M
Puts
$23.9M
Net Calls
+$30.8M
Net Calls Change
-$90.8M
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$6.09M +$611K +43,421 +14%
Goldman Sachs
52
Goldman Sachs
New York
$5.72M -$7.63M -542,609 -62%
BA
53
BlackRock Advisors
Delaware
$5.65M +$3.32M +236,204 +243%
VKH
54
Virtu KCG Holdings
New York
$5.65M -$1.73M -123,043 -27%
AllianceBernstein
55
AllianceBernstein
Tennessee
$5.61M +$354K +25,150 +8%
SCM
56
Stevens Capital Management
Pennsylvania
$5.46M +$4.53M +322,251 New
LOM
57
Loeb Offshore Management
New York
$5.34M +$4.43M +315,000 New
Allianz Asset Management
58
Allianz Asset Management
Germany
$5.28M -$412K -29,283 -9%
AIMCA
59
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$5.08M -$3.84M -272,820 -48%
TA
60
Teachers Advisors
New York
$5.08M -$6.25M -443,950 -60%
Citigroup
61
Citigroup
New York
$4.98M +$4.05M +287,657 +4,795%
Millennium Management
62
Millennium Management
New York
$4.63M -$47.1M -3,349,443 -92%
Swiss National Bank
63
Swiss National Bank
Switzerland
$3.54M +$196K +13,900 +7%
IHM
64
Iguana Healthcare Management
New York
$3.39M -$352K -25,000 -11%
PCM
65
Prelude Capital Management
New York
$3.38M +$2.81M +199,552 New
WRBC
66
W.R. Berkley Corp
Connecticut
$3.01M +$2.5M +177,563 New
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$2.93M +$375K +26,665 +18%
ProShare Advisors
68
ProShare Advisors
Maryland
$2.87M +$184K +13,052 +8%
Ameriprise
69
Ameriprise
Minnesota
$2.83M -$14.7M -1,042,945 -86%
EPM
70
Equitec Proprietary Markets
Illinois
$2.78M +$2.31M +164,100 New
AA
71
Ancora Advisors
Ohio
$2.63M +$2.18M +155,168 New
MCM
72
Moore Capital Management
New York
$2.54M +$703K +50,000 +50%
BPGAM
73
BTG Pactual Global Asset Management
Bermuda
$2.54M +$2.11M +150,000 New
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$2.51M +$189K +13,469 +10%
NFA
75
Nationwide Fund Advisors
Ohio
$2.48M +$214K +15,235 +12%

AVNR Hedge Fund Activity: Q4 2014 in Review

166 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q4 2014, worth a combined $2.74B — up 42% from $1.93B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new AVNR positions and 44 closed out — a net gain of 25 holders — while 45 added to existing stakes and 42 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $247M. The largest seller was Fidelity Investments, cutting an estimated $219M.

  • 166 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q4 2014, up from 142 in Q3 2014.
  • Funds reported $2.74B of AVANIR PHARMACEUTICALS, INC CL A stock for Q4 2014, up 42% quarter-over-quarter.
  • 69 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q4 2014 and 44 closed out, a net change of +25 holders.
  • The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q4 2014 was Baker Bros. Advisors, an estimated $247M added.
  • The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q4 2014 was Fidelity Investments, an estimated $219M sold.

Based on aggregated 13F filings for Q4 2014.